Best Doctors in Italy — Get an Online Consultation

After graduating in Medicine and Surgery, Dr. Saltutti specialized in Urology, gaining advanced expertise in treating disorders of the male and female urinary system, as well as the male reproductive system. Throughout his professional journey, he has focused on innovative and minimally invasive surgical techniques, such as robotic and laparoscopic surgery, especially for the treatment of prostate, kidney, and bladder cancers.

Over the years, Dr. Saltutti has attended numerous national and international conferences, expanding his knowledge and contributing to the advancement of therapeutic and surgical techniques in the urological field. He is known for his clinical expertise and dedication to his patients, adopting a personalized approach to each case to ensure effective, high-quality care.

His work at GVM facilities, which boast cutting-edge technologies and a highly qualified medical team, allows Dr. Saltutti to offer comprehensive services ranging from early diagnosis to treatment and post-operative rehabilitation. His areas of specialization include, in addition to urological cancers, the treatment of prostate conditions, kidney stones, urinary incontinence, and male sexual dysfunction.

Thanks to his experience and passion for the medical profession, Dr. Carlo Saltutti is a reference point for patients seeking excellent urological care at the GVM group

Dr. Borghesi leads the Neurosurgery Unit at Maria Cecilia Hospital, where his team performs around 1,000 advanced neurosurgical procedures annually. His approach combines years of experience with the latest technological innovations to ensure patients receive the most effective treatments available. Specializing in spinal surgeries (including cervical, dorsal, and lumbar procedures), Dr. Borghesi utilizes both posterior and anterior techniques to help patients regain mobility and relieve pain. Throughout his career, he has successfully performed over 4,500 complex surgeries, offering life-changing solutions for patients with challenging cranial and spinal conditions.

For brain tumor removal, he and his team employ advanced video-micro-surgical techniques, including the use of a digital microscope with 4K 3D imaging, which allows for enhanced precision and minimal invasiveness. Patients suffering from conditions like trigeminal neuralgia, facial spasms, and tumors of the posterior cranial fossa can benefit from Dr. Borghesi’s expertise in minimally invasive surgery, having treated over 400 cases with innovative techniques.

• Spinal Surgery: Expert in performing complex spinal surgeries (cervical, thoracic, and lumbar) using the latest methods to treat conditions such as herniated discs, spinal degeneration, and more.
• Brain Tumor Removal: Specializes in minimally invasive brain surgery for the removal of extensive tumors using cutting-edge 3D orbital camera technology.
• Trigeminal Neuralgia: Successfully treated over 400 cases of trigeminal neuralgia and other cranial nerve disorders with minimally invasive techniques, providing relief for patients with less recovery time.
• Colloid Cyst Removal: The doctor specializes in complex surgeries to remove this benign but very rare tumor.

Dr. Borghesi has trained in various top-tier international hospitals, learning from the best to provide high-quality care to his patients:

• Spinal Unit at Schulthess Klinik in Zurich
• École de Chirurgie in Paris, specializing in skull base and spinal surgeries
• Brain Institute at the University of Florida, specializing in microsurgical brain procedures
• Microsurgical Laboratory at the University of Arkansas, with a focus on lumbar degenerative disorders

He is the author of numerous scientific publications in national and international journals and volumes. In 1997 he was consultant of the "Medical Review" Journal.

In 1995 he graduated at the Faculty of Medicine and Surgery form the Catanzaro University “Magna Graecia”, where, in 2001, he specialized in Internal Medicine. In 2006 he attended the “State of the Art in AFIB and HF Treatments” course directed by Dr. Carlo Pappone. In 2014 he attended the Heart Rhythm Management Center Universitair Ziekenhuis in Brussel and obtained the certification for the procedures for the treatment of atrial fibrillation using cryoenergy (Cryoballon Training Program). In 2015, he was certified for MICRA-TPS leadless pacemaker implantation procedures at Medtronic Training Center in Minneapolis (MICRA-TPS Training Program).

Dr Iacopino is a member of important national and international scientific societies such as the American College of Cardiology, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association and the European Society of Cardiology. He directs several study projects, applicable to great benefit for the patient on the identification of rare syndromes associated with arrhythmias and heart failure, such as Brugada syndrome, or Wolff-Parkinson-White syndrome. He recently tested, for the first time in Italy, the CardioInsight, an innovative hi-tech jacket for 3D mapping of the heart rhythm disturbances. He has participated and hosted numerous medical conferences around the world, providing theoretical and practical preparation for the various interventional procedures aimed at electrophysiologists and electrophysiology technicians from all over Italy and abroad (United Kingdom, Germany, Spain, Russia). He was a member of the AIAC National Electrophysiology and Ablation Registry, the AIAC Lead Extraction National Registry and the AIAC Pacemaker and Implantable Defibrillator National Registry.

He is author or co-author of several publications and interventions in prestigious medical journals (total impact factor: 169.098).

He has been awarded different fellowships: 

- Fellowship ANMCO (National Association of Hospital Cardiologists), Florence, 3 June 2007; 

- Fellowship ESC (European Society of Cardiology), Munich, 1 September 2008; 

- Fellowship ACC (American College of Cardiology), Atlanta, February 1, 2010

Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.

After receiving his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology, Dr. Della Torre worked for 3 years in the United States at the “Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard Medical School” in Boston. Thanks to a Cariplo Foundation research grant, Dr. Della Torre returned to Italy in 2018 and established his lab within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy).

Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital.

Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and achieved prestigious awards such as the Collegio Ghislieri and the Cariplo Foundation awards for young researchers, the TRIDEO award, the MyFirst AIRC research grant, and the Career Research Grant Award from the FOREUM Foundation.

With his seminal works Dr. Della Torre contributed to the characterization of a novel autoimmune disease known as “IgG4-related disease” and is currently considered “World Expert of IgG4-related disease” by the prestigious Expertscape platform.

Dr. Della Torre is the Disease Coordinator of the IgG4-related disease European working group of the European Reference Network (ERN) on Rare Connective Tissue and Musculoskeletal Diseases (ReCONNET).

Up to September 2022, his scientific publications received more than 6000 citations with an H-index of 35.

Dr. Della Torre presented his studies in different national and international immune-rheumatologic congresses, organized a number of scientific meetings, and co-authored 10 medical books. He presently serves as reviewer for more than 50 peer-reviewed journals and as associated editor for three international scientific journals. Dr. Della Torre is a Head of the:

• IgG4-Related Disease Clinic
• Autoimmune pancreatitis Clinic
• Retroperitoneal Fibrosis Clinic at San Raffaele Hospital (Milan, Italy)

Dr. Lolli is a highly accomplished orthopedic surgeon specializing in spine surgery, with over two decades of expertise in treating complex spinal conditions. Graduating with top honors in Medicine and Surgery from the prestigious University of Bologna in 2004, he further honed his skills by specializing in Orthopedics and Traumatology.

Currently, Dr. Lolli is a key member of the Neurosurgery and Spine Surgery Department at the renowned Maria Cecilia Hospital, where he focuses on advanced treatments for spinal deformities in both teenagers and adults. His extensive background includes over a decade of work at the world-renowned Rizzoli Orthopedic Institute, one of Europe’s top orthopedic centers, where he was a spine surgery specialist from 2003 to 2015.

Dr. Lolli’s surgical expertise is reflected in the more than 3.000 spine surgeries he has performed, particularly in correcting vertebral deformities such as scoliosis and kyphosis. His proficiency spans treating both congenital and neuromuscular scoliosis in children and adolescents, using state-of-the-art techniques like growing rods and VEPTR for early onset scoliosis. He is also highly skilled in advanced vertebral resection techniques, including Smith Petersen, Ponte, and pedicle subtraction osteotomies.

In addition to pediatric spine deformities, Dr. Lolli has vast experience addressing degenerative spine conditions, such as herniated discs, spondylolisthesis, and spinal stenosis, using both traditional and cutting-edge non-fusion techniques.

An active member of the AO Spine association, Dr. Lolli contributes to global education and research in spine care. His academic contributions are extensive, with over 30 publications in leading medical journals (Spine, European Spine Journal, The Spine Journal) and more than 100 reports presented at national and international conferences. He has also been a keynote speaker at numerous prestigious events, including the Global Spine Congress and the Bologna Spine Meeting.

Dr. Lolli’s dedication to advancing spine surgery and improving patient outcomes has made him a respected figure in the field, both in Italy and internationally.

Education Dr. Castriota graduated in Medicine and Surgery from the University of Milan. He continued his postgraduate training at the University of Bologna where he obtained two specializations: the first one in Cardiology in 1992 and then in Radiology. From 1995 to 1996 he spent a period as a Fellow in the "Arizona Heart Institute" under the supervision of Professor Diethrich.

Research Dr. Castriota is an active member of some scientific societies, such as SIRM (Italian Society of Medical Radiology), Fellow of the Scientific College of the Italian Society of Invasive Cardiology (GISE), Fellow of the European Society of Cardiology (FESC), European Cardiovascular Interventional Society (EAPCI) and of ISES, International Society of Endovascular Specialist. He is the principal investigator of a recent Protected TAVR study, aimed at evaluating the effectiveness of a particular device for brain protection during aortic valve replacement surgery using the TAVI endovascular method.

Publications He is a member of the International Editorial Board of Eurointervention, speaker and chairman for the execution of live cases in national and international conferences.

Author of about 150 full-length publications

Author of over 20 chapters in specialized volumes

Awards: NHMRC Career Development Fellowship, Australian National Health and Medical Research Council, 2015.

Professor Riccardo Rosati is the Head of the Gastrointestinal Surgery (GI) Department at the San Raffaele Research Hospital in Milan, Italy. He is a highly experienced surgeon with over 30 years of experience, having completed medical degrees in general medicine and general surgery, as well as specialization in thoracic surgery. He is a member of multiple surgical associations, and has written over 300 publications. His department treats approximately 2,000 surgical cases per year.

Associate Professor of Thoracic Surgery with European Board qualifications. Head of mini-invasive thoracic surgery unit, specializing in the treatment of lung and pleural diseases and mediastinal disorders. Member of Italian Society of Thoracic Surgery and Thoracic Endoscopy, as well as author of a monograph and over 200 scientific publications.

Dr. Giorgia Mangili is the Head of the Medical Gynecological Oncology Group at the San Raffaele Scientific Institute Hospital since 2002. She has a degree in general medicine and specialties in gynecology and obstetrics, oncology, and is an Associate and Professor in obstetrics and gynecology. She focuses her work on gynaecological oncology, rare gynaecological tumours, preservation of fertility in oncology and cancer and pregnancy. She is a member of the European Organisation for Treatment of Trophoblastic Diseases, the European Society of Gynaecological Oncology, and the Italian Society of Gynecologic Oncology.

Professor Pietro Mortini MD is a highly experienced Italian neurosurgeon who specializes in neuro- and radiosurgeries with a focus on minimally invasive spine and brain operations. He is a Visiting Professor at the George Washington University, has a degree in Otorhinolaryngology and Neurosurgery from the University of Milan and University of Verona, and has patented a method of manufacturing a device for regenerating biological tissues. He also provides research in microsurgical therapy of pituitary adenomas and radiosurgery for uveal melanoma and is a member of the Italian Society of the Cranial Base.

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).